Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo

SIMPLE SUMMARY: The clinical management for aggressive meningiomas remains challenging due to the lack of systemic treatment options. Receptor tyrosine kinases (RTKs) are frequently overexpressed in meningiomas and are associated with poor patient survival. In this study, we evaluated the clinically...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Tao, Cao, Junguo, Alaa Eddine, Montadar, Moustafa, Mahmoud, Mock, Andreas, Erkut, Cihan, Abdollahi, Amir, Warta, Rolf, Unterberg, Andreas, Herold-Mende, Christel, Jungwirth, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657092/
https://www.ncbi.nlm.nih.gov/pubmed/34885009
http://dx.doi.org/10.3390/cancers13235898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657092/
https://www.ncbi.nlm.nih.gov/pubmed/34885009
http://dx.doi.org/10.3390/cancers13235898

Ejemplares similares